Long term clinical outcomes of patients with ischemic stroke in primary care - a 9-year retrospective study

被引:5
作者
Han, Jinghao [1 ]
Choi, Yue Kwan [1 ]
Leung, Wing Kit [1 ]
Hui, Ming Tung [1 ]
Leung, Maria Kwan Wa [1 ]
机构
[1] Hosp Author, Dept Family Med, New Terr East Cluster, Hong Kong, Peoples R China
关键词
Stroke; Cardiovascular disease (CVD) risk; Secondary prevention; Statin; Primary care; BLOOD-PRESSURE; RECURRENT STROKE; PREVENTION; RISK; SURVIVAL; STATINS; POPULATION; INFARCTION; THERAPY; DEATH;
D O I
10.1186/s12875-021-01513-w
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background We aim to document the long-term outcomes of ischemic stroke patients and explore the potential risk factors for recurrent cardiovascular events and all-cause mortality in primary care. Methods A retrospective cohort study performed at two general out-patient clinics (GOPCs) under Hospital Authority (HA) in Hong Kong (HK). Ischemic stroke patients with at least two consecutive follow-up visits during the recruitment period (1/1-30/6/2010) were included. Patients were followed up regularly till the date of recurrent stroke, cardiovascular event, death or 31/12/2018. The primary outcome was the occurrence of recurrent cerebrovascular event including transient ischemic stroke (TIA), ischemic stroke or hemorrhagic stroke. The secondary outcomes were all-cause mortality and coronary artery disease (CAD). We fit cox proportional hazard model adjusting death as competing risk factor to estimate the cause-specific hazard ratio (csHR). Results A total of 466 patients (mean age, 71.5 years) were included. During a median follow-up period of 8.7 years, 158 patients (33.9%) died. Eighty patients (17.2%) had recurrent stroke and 57 (12.2%) patients developed CAD. Age was an independent risk factor for recurrent stroke, CAD and death. Statin therapy at baseline had a protective effect for recurrent stroke (csHR = 0.476; 95% confidence interval [CI] 0.285-0.796, P = 0.005) after adjusting death as a competing risk factor and all-cause mortality (HR = 0.693, 95% CI 0.486-0.968, P = 0.043). In addition, female sex, antiplatelet and a higher diastolic blood pressure (DBP) at baseline were also independent predictors for survival. Conclusions Long term prognosis of ischemic stroke patients in primary care is favorable. Use of statin was associated with a significant decrease in stroke recurrence and mortality. Patients who died had a significant lower DBP at baseline, highlighted the need to consider both systolic and diastolic blood pressure in our daily practice.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] Amarenco P, 2006, NEW ENGL J MED, V355, P549
  • [2] [Anonymous], The top 10 causes of death
  • [3] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [4] Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
    Boehm, Michael
    Schumacher, Helmut
    Teo, Koon K.
    Lonn, Eva M.
    Mahfoud, Felix
    Mann, Johannes F. E.
    Mancia, Giuseppe
    Redon, Josep
    Schmieder, Roland E.
    Sliwa, Karen
    Weber, Michael A.
    Williams, Bryan
    Yusuf, Salim
    [J]. LANCET, 2017, 389 (10085) : 2226 - 2237
  • [5] Brown F, 2017, CAN FAM PHYSICIAN, V63, pE495
  • [6] Centre for Health protection, VIT STAT DEATH RAT L VIT STAT DEATH RAT L
  • [7] Statins Improve Survival in Patients With Cardioembolic Stroke
    Choi, Jeong-Yoon
    Seo, Woo-Keun
    Kang, Sung Hoon
    Jung, Jin-Man
    Cho, Kyung-Hee
    Yu, Sungwook
    Oh, Kyungmi
    [J]. STROKE, 2014, 45 (06) : 1849 - +
  • [8] Implementation of secondary stroke prevention protocol for ischaemic stroke patients in primary care
    Choi, Y. K.
    Han, J. H.
    Li, Richard
    Kung, Kenny
    Lam, Augustine
    [J]. HONG KONG MEDICAL JOURNAL, 2015, 21 (02) : 136 - 142
  • [9] Recurrent stroke and cardiac risks after first ischemic stroke - The Northern Manhattan Study
    Dhamoon, MS
    Sciacca, RR
    Rundek, T
    Sacco, RL
    Elkind, MSV
    [J]. NEUROLOGY, 2006, 66 (05) : 641 - 646
  • [10] Secondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study
    Eriksson, Sven-Erik
    [J]. BRAIN AND BEHAVIOR, 2017, 7 (01):